• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

303
75
51
51
35

COUNTRY

34
13
13
12
12

PRICE

757
915
1,243
1,695

PUBLISHED

6
42
299
1,695

PRODUCT TYPE

1,093
499
85
16
2

Infectious Diseases

Antibiotics, antifungals, antivirals and other infectious disease pharmaceuticals account for a multibillion sector. The battle against contagious diseases takes places in a highly changeable environment, with a wealth of commercial opportunities arising from quickly emerging threats (e.g. avian flu) and the infectious disease and vaccination policies of national governments and international healthcare organisations. Keep track of the latest industry news and activity with the publications listed under Research and Markets’ Infectious Diseases category.

Our reports, books, and subscriptions will allow you to explore licensing, patents, forecasts, market trends, clinical trials, and drug pipelines. Leading players featured in our publications include Pfizer, Roche, Novartis, AstraZeneca, Sanofi, Johnson & Johnson, Merck, Abbott, GlaxoSmithKline, Lilly, and more.

For publications about Infectious Disease Testing please visit the relevant category under Healthcare and Medical Devices. Show Less
Read more

PRODUCT TITLE

Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2014

Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2014 Summary This, ‘Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2014’, provides an overview of the Respiratory...

July 2014
FROM

Varicella Zoster (HHV-3) Infections - Pipeline Review, H2 2014

Varicella Zoster (HHV-3) Infections - Pipeline Review, H2 2014 Summary This, ‘Varicella Zoster (HHV-3) Infections - Pipeline Review, H2 2014’, provides an overview of the Varicella Zoster (HHV-3)...

July 2014
FROM

Helicobacter Pylori Infections - Pipeline Review, H2 2014

Helicobacter Pylori Infections - Pipeline Review, H2 2014 Summary This, ‘Helicobacter Pylori Infections - Pipeline Review, H2 2014’, provides an overview of the Helicobacter Pylori Infections’s therapeutic...

July 2014
FROM

Global Infection Prevention and Control Market 2014-2018

About Infection Prevention and Control Infection prevention and control is the most important and significant step in the development and maintenance of products in the Medical Devices, Pharmaceuticals,...

July 2014
FROM

Smallpox - Pipeline Review, H2 2014

Smallpox - Pipeline Review, H2 2014 Summary This, ‘Smallpox - Pipeline Review, H2 2014’, provides an overview of the Smallpox’s therapeutic pipeline. This report provides comprehensive information...

July 2014
FROM

Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H2 2014

Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H2 2014’,...

July 2014
FROM

Cholera - Pipeline Review, H2 2014

Cholera - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Cholera - Pipeline Review, H2 2014’, provides an overview of the Cholera’s therapeutic pipeline. This report provides comprehensive...

July 2014
FROM

OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020

OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020 Summary Dengue is a febrile illness caused by the dengue virus (DENV), a single-stranded flavivirus most commonly transmitted...

July 2014
FROM

Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H1 2014

Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline...

June 2014
FROM

H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2014

H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2014’, provides an overview of the H5N1 Infection...

June 2014
FROM

Anthrax - Pipeline Review, H1 2014

Anthrax - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Anthrax - Pipeline Review, H1 2014’, provides an overview of the Anthrax’s therapeutic pipeline. This report provides comprehensive...

June 2014
FROM

Burkholderia Infections - Pipeline Review, H1 2014

Burkholderia Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Burkholderia Infections - Pipeline Review, H1 2014’, provides an overview of the Burkholderia Infections’s therapeutic...

June 2014
FROM

Warts - Pipeline Review, H1 2014

Warts - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Warts - Pipeline Review, H1 2014’, provides an overview of the Warts’s therapeutic pipeline. This report provides comprehensive...

June 2014
FROM

Bacterial Vaginosis - Pipeline Review, H1 2014

Bacterial Vaginosis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Bacterial Vaginosis - Pipeline Review, H1 2014’, provides an overview of the Bacterial Vaginosis’s therapeutic pipeline. This...

June 2014
FROM

Francisella Tularensis Infections - Pipeline Review, H1 2014

Francisella Tularensis Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Francisella Tularensis Infections - Pipeline Review, H1 2014’, provides an overview of the Francisella...

June 2014
FROM

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2014

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2014’, provides an overview of the Hospital Acquired...

June 2014
FROM

Ebola and Marburg Infections - Pipeline Review, H1 2014

Ebola and Marburg Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Ebola and Marburg Infections - Pipeline Review, H1 2014’, provides an overview of the Ebola and Marburg Infections’s...

June 2014
FROM

Tularaemia - Pipeline Review, H1 2014

Tularaemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Tularaemia - Pipeline Review, H1 2014’, provides an overview of the Tularaemia’s therapeutic pipeline. This report provides...

June 2014
FROM

Hepatitis D - Pipeline Review, H1 2014

Hepatitis D - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hepatitis D - Pipeline Review, H1 2014’, provides an overview of the Hepatitis D’s therapeutic pipeline. This report provides...

June 2014
FROM

Shigella Infections (Shigellosis) - Pipeline Review, H1 2014

Shigella Infections (Shigellosis) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Shigella Infections (Shigellosis) - Pipeline Review, H1 2014’, provides an overview of the Shigella Infections...

June 2014
FROM
Loading Indicator

Our Clients

Our clients' logos